Turkish Society of Cardiology consensus paper on management of arrhythmia-induced cardiomyopathy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Echocardiographic assessment in cardiogenic shock.Herz · 2021
   Review
2. Miocardiopatía inducida por arritmia: informe de caso.Archivos de cardiologia de Mexico · 2021
   Article
3. Perspectives by a position statement on atrial fibrillation in acute heart failure a: Mechanisms and therapeutic approaches.Anatolian journal of cardiology · 2020
   Review
4. Review of the 2019 European Society of Cardiology Guidelines for the management of patients with supraventricular tachycardia: What is new, and what has changed?Anatolian journal of cardiology · 2019
   Review
5. Radiofrequency ablation for fascicular ventricular tachycardia causing tachycardiomyopathy and brief literature review.Annals of pediatric cardiology
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

10 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as